Renovascular Hypertension in Bradykinin B2-Receptor Knockout Mice

Authors:

Abstract
—We evaluated whether kinins exert a protective action against the development of two-kidney, one clip (2K1C) hypertension, a model characterized by an activated renin-angiotensin system in the ischemic kidney and increased expression of the bradykinin (BK) B2receptor in the contralateral kidney. BK B2-receptor knockout (B2−/−), wild-type (B2+/+), and heterozygous (B2+/−) mice underwent clipping of the left renal artery, with the other kidney remaining untouched. Basal systolic blood pressure (SBP, via tail-cuff plethysmography) was higher in B2−/−mice than in B2+/−or B2+/+mice (121±2 versus 113±2 and 109±1 mm Hg;P2−/−mice than in B2+/−or B2+/+mice (28±2 versus 14±2 and 14±2 mm Hg, respectively, at 2 weeks;P2receptor by Icatibant enhanced the pressure response to clipping in B2+/+mice (29±2 mm Hg at 2 weeks). Intra-arterial mean blood pressure (MBP) was higher in 2K1C than in respective sham-operated mice, with the MBP difference being higher in B2−/−mice (32 and 38 mm Hg, at 2 and 4 weeks, respectively), and higher in B2+/+mice given Icatibant (30 and 32 mm Hg) than in B2+/+mice without Icatibant (17 and 18 mm Hg). At 4 weeks, acute injection of an angiotensin type 1 receptor antagonist normalized the MBP of 2K1C hypertensive mice. A tachycardic response was observed 1 week after clipping in B2−/−and B2+/−mice, but this effect was delayed in B2+/+mice. However, the HR response to clipping in B2+/+mice was enhanced by Icatibant. Within each strain, heart weight to body weight ratio was greater in 2K1C hypertensive mice than in sham-operated control animals (B2−/−: 5.7±0.1 versus 5.2±0.1; B2+/+: 5.1±0.1 versus 4.5±0.1;P2receptor exert a protective action against excessive blood pressure elevation during early phases of 2K1C hypertension.